Mycobacterium tuberculosis proteome-wide epitope discovery and host transcriptome-wide T cell phenotyping in high disease burden populations
Active Definitive Contract Awarded Last action
- Contract number
- 75N93024C00054
- Awardee
-
The Translational Genomics Research Institute UEI J19ZXYATJLT3
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $4,088,181
Award facts
- Opportunity
-
- Large-scale T cell immune epitope discovery and mechanisms of T cell protection Pre-Solicitation · 75N93022R00023 · Posted Mar 6, 2023
- Contract value 60% obligated
-
- $4,088,181.00 Current, with exercised options
- $6,778,661.00 Potential, with all options
- Completion date 70% complete
- Current and potential, with all options
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 12 offers Negotiated Proposal / Quote
- Pricing
- Cost No Fee
- Place of performance
- Phoenix, AZ 85004, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | $1,542,506 | |
| Other Administrative Action | $0 | |
| Change Order | $1,040,738 | |
| Original award | $1,504,937 |
About this award
The National Institute of Allergy and Infectious Diseases awarded a $6.78 million definitive contract to Translational Genomics Research Institute (doing business as Tgen Research Institute) for mycobacterium tuberculosis proteome-wide epitope discovery and host transcriptome-wide T cell phenotyping in high-disease-burden populations on September 30, 2024, under a cost no-fee pricing structure with no set-aside.
The originating pre-solicitation, posted March 6, 2023, sought proposals for multi-disciplinary research teams to conduct large-scale discovery and validation of T cell immune epitopes associated with infectious diseases, autoimmune diseases, commensal organisms, or alloantigens influencing transplant outcomes. The pre-solicitation anticipated five-year cost-reimbursement awards with an estimated average annual cost of $1.25 million per contract and signaled that multiple awards would be made.
Place of performance is Phoenix, Arizona. The contract is scheduled for ultimate completion on September 29, 2027.
Quick answers
Who was awarded contract 75N93024C00054?
75N93024C00054 was awarded to The Translational Genomics Research Institute by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on September 30, 2024.
How much is contract 75N93024C00054 worth?
The government has obligated $4,088,181 on 75N93024C00054. Its potential value, with all options, is $6,778,661.
Was contract 75N93024C00054 competed?
The extent of competition for 75N93024C00054 was full and open competition. The government received 12 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award